Cite
HARVARD Citation
Gover-Proaktor, A. et al. (2019). Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells. Leukemia & lymphoma. 60 (1), pp. 189-199. [Online].